The effect of new anthracycline derivatives on the induction of apoptotic processes in human neoplastic cells

Folia Histochemica et Cytobiologica

Volumn 42, Issue 2, 2004, Pages 127-130

  Gruber, Beata M ^a   Anuszewska, Elzbieta L ^a   Priebe, Waldemar ^b  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adriamycin; Anthracycline derivatives; Apoptosis; Drug resistance; Neoplastic cells

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PROPIDIUM IODIDE; UNCLASSIFIED DRUG; WP 903;

APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MELANOMA CELL; NICK END LABELING; TUMOR CELL;

EID: 2642584240     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Arcamone F, Animati F, Capranico G, Lombardi P, Pratesi G, Manzini S, Supino R, Zunino F (1997) New developments in antitumor anthracyclines. Pharmacol Ther 76: 117-124
2. Binaschi M, Capranico G, Dal Bo L, Zunino F (1997) Relationship between lethal effects and topoisomerase II-mediated double-stranded DNA breaks produced by anthracycline with different sequence specificity. Mol Pharmacol 51: 1053-1059
3. Chłopkiewicz B (1996) Screening tests for evaluation of potential mutagenic and genotoxic properties of chemical substances (in Polish). Biuletyn IL 40: 10-20
4. Cullinane C, Cutts SM, van Rosmalen A, Philips DR (1994) Formation of adriamycin-DNA adducts in vitro. Nucleic Acids Res 22: 2296-2303
5. Drag-Zalesińska M, Wysocka T, Dumańska M, Jagoda E, Zabel M (2002) Comparison of techniques permitting to detect apoptosis in situ. Folia Histochem Cytobiol 40: 125-126
6. Fornari FA, Randolph JK, Yalowich JC, Ritke MK, Gewinz DA (1994) Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol 45: 649-656
7. Gewirtz DA (1999) A critical evaluation of the mechanism of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57: 727-741
8. Gruber B (1996) Enzymes protecting the organism from reactive oxygen species (in Polish). Farm Pol 52: 263-271
9. Gruber BM, Anuszewska EL (2001) Assessment of the cytotoxic effect of new anthracycline derivatives in the model of various cell lines (in Polish). Biuletyn IL 45: 569-578
10. Gruber BM, Anuszewska EL, Skierski JS (2001) Activation of programmed cell death (apoptosis) by adriamycin in human neoplastic cells. Mutation Res 484: 87-93
11. Ling YH, Priebe W, Perez-Soler R (1993) Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res 53: 1845-1852
12. Mazur L, Czyzewska A (2001) Immunocytochemical analysis of apoptotic bone marrow cells after treatment of mice with WR-2721 and chemotherapeutic drugs. Folia Histochem Cytobiol 39: 63-66
13. Müller I, Jenner A, Bruchelt G, Niethammer D, Halliwell B (1997) Effect of concentration on the cytotoxic mechanism of doxorubicin-apoptosis and oxidative DNA damage. Biochem Biophys Res Commun 230: 254-257
14. Odom AL, Hatwig CA, Stanley JS, Benson AM (1992) Biochemical determinants of adriamycin toxicity in mouse liver, heart and intestine. Biochem Pharmacol 43: 831-836
15. Priebe W, Perez-Soler R (1993) Design and tumor targeting of anthracyclines able to overcome multidrug resistance: a double-advantage approach. Pharmacol Ther 60: 215-234